Richard A. Fair - 11 Dec 2025 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Reporting relationship: PRESIDENT AND CEO, Director
Issuer ticker: ELVN
Reported as of: 11 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Dec 2025, 18:31:31 UTC
Prior SEC filing: 16 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Ben Hohl, by power of attorney

Key filing fact

Richard A. Fair filed Form 4 for Enliven Therapeutics, Inc. (ELVN) on 12 Dec 2025.

Key facts

This page summarizes Richard A. Fair's Form 4 filing for Enliven Therapeutics, Inc. (ELVN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Dec 2025, 18:31.

Change

Previous filing in this sequence was filed on 16 Aug 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001695851 Primary reporting owner

Fair Richard A.

Relationship: PRESIDENT AND CEO, Director
Address: C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER
Signature: /s/ Ben Hohl, by power of attorney
Signature date: 12 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELVN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +875,000
Change %
Price: $0.000000
Shares after: 875,000
Date: 11 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 875,000
Exercise price: $18.77
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/4th of the shares subject to the option will vest on December 11, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.